Multimodality radiomics for tumor prognosis in nasopharyngeal carcinoma
- 1Department of Radiological Technology and Medical Physics, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
- 2Chulalongkorn University Biomedical Imaging Group, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- 3Division of Radiation Oncology, Department of Radiology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
- 4Division of Radiation Oncology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- 5Center for Artificial Intelligence in Medicine, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- 6Center of Excellence in Computational Molecular Biology, Chulalongkorn University, Bangkok, Thailand.
- 7Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
- 0Department of Radiological Technology and Medical Physics, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok, Thailand.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Radiomic features from CT and MR images significantly improve predictions of overall survival, progression-free survival, and distant metastasis-free survival in nasopharyngeal carcinoma (NPC) patients. This approach enhances prognostic accuracy beyond traditional clinical data.
Area Of Science
- Oncology
- Radiology
- Medical Imaging Analysis
Background
- Nasopharyngeal carcinoma (NPC) prognosis is difficult due to late detection and undetectable Epstein-Barr virus (EBV) DNA.
- Radiomic features, quantifying tumor imaging characteristics, offer potential for improved NPC prognosis assessment.
Purpose Of The Study
- To evaluate the predictive capability of radiomic features for overall survival (OS), progression-free survival (PFS), and distant metastasis-free survival (DMFS) in NPC.
- To assess the added value of radiomics in conjunction with clinical data for NPC survival prediction.
Main Methods
- Retrospective analysis of 183 NPC patients treated with chemoradiotherapy (2010-2019) with a minimum three-year follow-up.
- Extraction of radiomic features from pretreatment CT and MR images using PyRadiomics v.2.0.
- Combination of selected radiomic features with clinical data (age, gender, stage, EBV DNA) for prognostic modeling using Cox regression with RFE and cross-validation.
Main Results
- Integration of radiomics with clinical data significantly improved predictive power (C-index 0.788-0.848) compared to clinical data alone (C-index 0.745-0.766, p<0.05).
- Multimodality radiomics combined with clinical data demonstrated the highest performance.
- Radiomics integration enhanced survival predictions even without EBV DNA data (C-index 0.770-0.831 vs. 0.727-0.734, p<0.05).
Conclusions
- Multimodality radiomic features from CT and MR images provide superior predictive performance for NPC survival outcomes (OS, PFS, DMFS).
- Radiomics integration offers a valuable tool for enhancing prognostic assessment in NPC, complementing traditional clinical data.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

